Canada announces $80M for Canadian Critical Drug Initiative co-led by UAlberta, API

The Government of Canada is providing $80M over five years to support new infrastructure for the Canadian Critical Drug Initiative, which is led by Applied Pharmaceutical Innovation (API) and the University of Alberta. The funds will support the construction of a 40,000-square-foot facility that will be able to produce new and critical medicines, as well as upgrades for an existing API research and development facility, enhanced programs that will train technicians and scientists in collaboration with universities across Canada, and clinical trials and commercial development of medical treatments. “[T]oday’s announcement will position the U of A and Alberta to play a leading role in strengthening Canada’s healthcare system,” said UAlberta President Bill Flanagan.